HPE conf
Biotech

US biotechs thinking twice about licensing drugs to Europe

U.S. biotechs are increasingly reluctant to license their drugs to European partners in order to avoid becoming a target of the Trump administration.
James Waldron Sep 26, 2025 8:09am
denovirus transmission replication treatments 3D scientific illustration

Biogen discontinues all AAV gene therapy work

Sep 26, 2025 11:04am
Fish oil pills sitting in a fish-shaped dish

Fatty acid eye injections restore vision in old mice

Sep 26, 2025 2:10pm
Essilor Luxottica Stellest expo booth

FDA clears 1st eyeglasses for slowing childhood nearsightedness

Sep 26, 2025 11:38am
workers

Fierce Biotech Layoff Tracker 2025: Biogen, Heidelberg & more

Sep 26, 2025 11:00am
DNA genome CRISPR gene editing

ARPA-H unveils programs to develop custom gene editing therapies

Sep 26, 2025 10:41am
More News

Eli Lilly opens latest incubator site in San Diego

Sep 26, 2025 9:55am

Fierce Biotech's Fierce 15

Sep 26, 2025 8:57am

Merck KGaA picks new pilot for turbulent times—Chutes & Ladders

Sep 26, 2025 8:30am
Fierce Pharma

Nominations open for Fiercest Women in Life Sciences—LAST DAY

Sep 26, 2025 7:00am